Appointment booking for Dr. Christopher Seaver, MD is currently not available.Dr. Christopher Seaver, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Christopher Seaver, MD (he/him) is a Surgeon in Pembroke Pines, FL with over 16 years of experience. What is your opinion of Dr. Christopher Seaver, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Christopher Seaver, MD has received over $13,988 which includes payments from the following companies:
$4,000.00 from Osiris Therapeutics Inc.
$3,739.98 from Intuitive Surgical, Inc.
$1,393.91 from Stryker Corporation
$932.28 from LifeCell Corporation
$914.44 from Allergan Inc.
$705.30 from Davol Inc.
$504.04 from Neomend, Inc.
$383.50 from Ethicon US, LLC
$284.66 from Medtronic Sofamor Danek USA, Inc.
$275.18 from Integra LifeSciences Corporation
$136.42 from Smith & Nephew, Inc.
$123.55 from Globus Medical, Inc.
$117.71 from CONMED Corporation
$100.00 from Thoratec Corporation
$91.93 from Baxter Healthcare
$91.60 from KCI USA, Inc
$66.66 from DePuy Synthes Sales Inc.
$58.03 from Covidien LP
$21.55 from ACell, Inc.
$17.67 from Organogenesis Inc.
Payments received by Dr. Christopher Seaver, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!